The same social media video behaviors that shape other purchases are influencing their health and wellness choices.
Distrust of unknown numbers is causing patients to ignore provider calls and potentially miss important healthcare information.
Patients' chatbot use for mental health gives clinicians more chances to correct misuse and promote informed AI decisions.
The healthcare cost crisis hits everyone, but especially Gen Z, making even modest steps like promoting lower-cost products and financial assistance an opportunity for healthcare players to improve their standing with strained patients.
Oura courts GLP-1 users with free ring sizing kit via Lilly tie-up, signaling how drugmakers are pairing therapies with digital health tools to boost engagement and long-term adherence.
Sunscreen myths go viral on TikTok, where Gen Z spends time. Yet they know the least about sun safety, making it critical for brands to highlight the sun protection benefits that resonate with them today.
CVS MinuteClinic’s new $49 virtual GLP-1 program matches Walgreens on price, but differentiation will still be difficult in a crowded telehealth weight loss market.
Doctors remain in charge of steering condition and treatment decisions, but have the added responsibility of interpreting chatbot guidance.
AbbVie’s $10.9 billion immunology bet highlights how acquisitions are increasingly used to fill pipeline gaps, while underscoring the pressure on buyers to convert promising assets into approved drugs and commercial success.
Americans are spending more on health and wellness, and the reasons have less to do with income than with institutional skepticism. That dynamic is creating a significant retail opportunity, one that major retailers are already moving to capture. "[Wellness] has evolved into a much broader concept that combines physical health and mental health and emotional balance and lifestyle habits and longevity," said EMARKETER analyst Rajiv Leventhal in a recent episode of "Behind the Numbers."
OpenLoop has a new offering to stand up telehealth brands in just one day, but speed will test patient trust, care quality, and oversight.
Morning Consult found the brand’s trust scores held up despite a wave of negative political and media attention.
General LLMs outperform clinical AI on medical tests, but physicians will still favor specialized tools for high-stakes care.
They must clearly distinguish their products from gray-market manufacturers caught in the FDA’s crosshairs.
AI Overviews answer many health questions directly, forcing online health brands to offer expertise and utility that users can’t skip.
As another state gains permission to import drugs from Canada, it strengthens the case for narrowing the gap between US and foreign drug prices.
Nutrition information is earning more attention at the shelf, making front-of-pack labels a stronger influence on purchases.
Some patients forgo care after AI advice, creating health risks and urgency for provider-backed tools.
New deals with Nvidia and Lilly give Abridge validation from industry giants as it courts healthcare AI buyers.
While consumers trust doctors, they increasingly rely on AI and influencers for wellness advice, making misinformation more accessible and elevating the value of physician-backed brand content.